FineMark National Bank & Trust’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-349
Closed -$15K 594
2016
Q4
$15K Sell
349
-137
-28% -$5.59K ﹤0.01% 867
2016
Q3
$21K Buy
486
+119
+32% +$5.33K ﹤0.01% 803
2016
Q2
$16K Hold
367
﹤0.01% 861
2016
Q1
$16K Buy
367
+8
+2% +$339 ﹤0.01% 815
2015
Q4
$15K Sell
359
-16
-4% -$674 ﹤0.01% 870
2015
Q3
$15K Sell
375
-145
-28% -$5.9K ﹤0.01% 908
2015
Q2
$22K Buy
520
+85
+20% +$3.63K ﹤0.01% 863
2015
Q1
$18K Sell
435
-41
-9% -$1.58K ﹤0.01% 898
2014
Q4
$18K Sell
476
-33
-6% -$1.19K ﹤0.01% 929
2014
Q3
$18K Buy
509
+184
+57% +$6.35K ﹤0.01% 908
2014
Q2
$11K Sell
325
-45
-12% -$1.5K ﹤0.01% 1017
2014
Q1
$13K Buy
370
+72
+24% +$2.52K ﹤0.01% 990
2013
Q4
$11K Sell
298
-172
-37% -$5.77K ﹤0.01% 997
2013
Q3
$15K Buy
470
+90
+24% +$2.93K ﹤0.01% 885
2013
Q2
$13K Buy
+380
New +$13.2K ﹤0.01% 896

Other funds holding FMS

FineMark National Bank & Trust's FMS Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Fresenius Medical Care (FMS) in Q1 2017, closing a stake of 349 shares — an estimated $15K sold.

FineMark National Bank & Trust first reported a position in FMS in Q2 2013 and held it in 15 quarters. The position peaked at $22K in Q2 2015. 186 funds tracked by Wall St. Rank hold FMS as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Fresenius Medical Care position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 349 Fresenius Medical Care shares in Q1 2017, an estimated $15K.
  • FineMark National Bank & Trust first reported a position in Fresenius Medical Care in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Fresenius Medical Care position peaked at $22K in Q2 2015.
  • 186 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.